
Sign up to save your podcasts
Or
Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)
4.4
2121 ratings
Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)
781 Listeners
1,314 Listeners
4,107 Listeners
3,487 Listeners
9,199 Listeners
1,705 Listeners
620 Listeners
154 Listeners
497 Listeners
262 Listeners
1,581 Listeners
557 Listeners
1,933 Listeners
1,110 Listeners
20,649 Listeners